Stock 000952 HUBEI GUANGJI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Hubei Guangji Pharmaceutical Co., Ltd.

Equities

000952

CNE0000010R5

End-of-day quote Shenzhen S.E.
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
5.78 CNY +0.87% Intraday chart for Hubei Guangji Pharmaceutical Co., Ltd. -3.99% -27.66%
04-25 Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Guangji Pharmaceutical Gets Nod to Produce Entecavir
MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Guangji Pharma to Establish Joint Innovation Laboratory With Jiangnan University
MT
Guangji Pharma to Borrow 281 Million Yuan From Bank to Support Acquisition Deals
MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Hubei Guangji Pharmaceutical Announces Profit Distribution Proposal for 2022
CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Guangji Pharma Registers Diabetes-Related Infection Drug
MT
Hubei Guangji Pharma to Invest 468 Million Yuan in Parkson Biotechnology Amid Bankruptcy Reorganization
MT
Hubei Guangji Pharma Signs 6MW Solar Power Project
MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Guangji Pharmaceutical Unit to Resume Production After Three-Month Stoppage
MT
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Hubei Guangji Pharmaceutical Jikang Medicine Co., Ltd. announced that it has received CNY 45 million in funding from Hubei Guangji Pharmaceutical Co., Ltd.
CI
Hubei Guangji Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2021, Payable on May 27, 2022
CI
Hubei Guangji Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Hubei Guangji Pharmaceutical Co., Ltd. Approves Cash Dividend for 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 000952 Stock
  4. News Hubei Guangji Pharmaceutical Co., Ltd.